David Shaw’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
David Shaw's VCYT Position: Q2 2026 in Review
David Shaw increased its Veracyte (VCYT) stake by 880% in Q2 2026, buying an estimated $15.6M and bringing the position to 413,037 shares worth $24.3M. The position accounts for 0.01% of the portfolio, ranked #1160.
David Shaw first reported a position in VCYT in Q4 2018 and has held it in 18 quarters since. 368 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- David Shaw held 413,037 shares of Veracyte worth $24.3M as of Q2 2026.
- David Shaw bought 370,902 Veracyte shares in Q2 2026, an estimated $15.6M.
- Veracyte made up 0.01% of David Shaw's portfolio in Q2 2026, its #1160 holding.
- David Shaw first reported a position in Veracyte in Q4 2018 and has held it in 18 quarters since.
- 368 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.